questionText: To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential role of GLP-1 medications in reducing inflammation and pain associated with lipoedema.
answerText: The Department has not made any assessment of the potential role of GLP-1 medications in reducing inflammation and pain associated with lipoedema. Newly licensed medicines are appraised by the National Institute for Health and Care Excellence (NICE), whic...
heading: Lipoedema: Medical Treatments